Theravance's (THRX) CEO Michael Aguiar on Q3 2015 Results - Earnings Call Transcript
Oct. 28, 2015 | Source: Seeking Alpha
Theravance (THRX) Q3 2015 Results - Earnings Call Webcast
Oct. 28, 2015 | Source: Seeking Alpha
Theravance's (THRX) CEO Michael Aguiar on Q2 2015 Results - Earnings Call Transcript
July 29, 2015 | Source: Seeking Alpha
Theravance (THRX) Q1 2015 Results - Earnings Call Webcast
May 6, 2015 | Source: Seeking Alpha
Theravance's (THRX) CEO Mike Aguiar on Q1 2015 Results - Earnings Call Transcript
May 6, 2015 | Source: Seeking Alpha
Theravance's (THRX) CEO Mike Aguiar on Q4 2014 Results - Earnings Call Transcript
Feb. 18, 2015 | Source: Seeking Alpha
Theravance (THRX) Q4 2014 Results - Earnings Call Webcast
Feb. 18, 2015 | Source: Seeking Alpha
Theravance's (THRX) CEO Mike Aguiar on Credit Suisse Healthcare Conference - Call Transcript
Nov. 13, 2014 | Source: Seeking Alpha
Theravance (THRX) Q3 2014 Results - Earnings Call Webcast
Oct. 30, 2014 | Source: Seeking Alpha
Theravance's (THRX) CEO Mike Aguiar on Q3 2014 Results - Earnings Call Transcript
Oct. 30, 2014 | Source: Seeking Alpha
Theravance's (THRX) CEO Rick Winningham on Q2 2014 Results - Earnings Call Transcript
Aug. 7, 2014 | Source: Seeking Alpha
Theravance's (THRX) CEO Rick Winningham Hosts 2014 Annual Meeting of Stockholders Conference
May 22, 2014 | Source: Seeking Alpha
Theravance's (THRX) CEO Rick Winningham on Bank of America Merrill Lynch 2014 Health Care Conferenc
May 13, 2014 | Source: Seeking Alpha
Theravance's (THRX) CEO Rick Winningham on Q1 2014 Results - Earnings Call Transcript
May 6, 2014 | Source: Seeking Alpha
Q1 2014 Theravance Inc Earnings Conference Call (THRX) Q1 2014 Results - Earnings Call Webcast
May 6, 2014 | Source: Seeking Alpha
Theravance Announces Positive Results From a Phase 2 Study of TD-9855 in Patients With Fibromyalgia
May 1, 2014 | Source: Seeking Alpha
Theravance's CEO Presents at Barclays Global Healthcare Conference (Transcript)
March 11, 2014 | Source: Seeking Alpha
Q4 2013 Theravance Inc Earnings Conference call (Webcast)
Feb. 7, 2014 | Source: Seeking Alpha
Theravance's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Feb. 7, 2014 | Source: Seeking Alpha
Theravance's Management Presents at 32nd Annual JPMorgan Healthcare Conference (Transcript)
Jan. 16, 2014 | Source: Seeking Alpha
Theravance's CEO Presents at Credit Suisse Healthcare Conference (Transcript)
Nov. 13, 2013 | Source: Seeking Alpha
Theravance Inc's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Oct. 24, 2013 | Source: Seeking Alpha
Theravance's CEO Reviews Phase 2b Study 0091 with its LAMA Candidate TD-4208 Results - Transcript
Sept. 5, 2013 | Source: Seeking Alpha
Theravance Inc (THRX) CEO Discusses Q2 2013 Results - Earnings Call Transcript
July 25, 2013 | Source: Seeking Alpha
Theravance's Management Presents at Goldman Sachs Healthcare Conference (Transcript)
June 13, 2013 | Source: Seeking Alpha
Theravance's CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
May 15, 2013 | Source: Seeking Alpha
Theravance and Elan Enter Into a 1 Billion Dollar Royalty Participation Agreement (Transcript)
May 13, 2013 | Source: Seeking Alpha
Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha
Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha
Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha
Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha
Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha
Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha
Theravance's CEO Hosts 2013 Annual Meeting of Stockholders Conference (Transcript)
April 24, 2013 | Source: Seeking Alpha
Theravance Management Presents at Barclays 2013 Global Healthcare Conference (Transcript)
March 14, 2013 | Source: Seeking Alpha
Theravance's CEO Presents at 2013 Citi Global Healthcare Conference (Transcript)
Feb. 27, 2013 | Source: Seeking Alpha
Theravance's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Feb. 13, 2013 | Source: Seeking Alpha
Theravance's CEO Presents at J.P. Morgan Global Healthcare Conference (Transcript)
Jan. 9, 2013 | Source: Seeking Alpha
Theravance's Management Presents at Credit Suisse 2012 Healthcare Conference (Transcript)
Nov. 14, 2012 | Source: Seeking Alpha
Theravance's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Oct. 30, 2012 | Source: Seeking Alpha
Theravance's Management Present at Morgan Stanley Global Healthcare Conference (Transcript)
Sept. 12, 2012 | Source: Seeking Alpha
Theravance, Inc. CEO Discusses Q2 2012 Earnings Results - Earnings Call Transcript
July 31, 2012 | Source: Seeking Alpha
Theravance's CEO Announces Positive Topline Results From TD-1211 Phase 2b Study 0084 for the Treatm
July 12, 2012 | Source: Seeking Alpha
Theravance's CEO Discusses LAMA/LABA Phase 3a Results Conference Call (Transcript)
July 2, 2012 | Source: Seeking Alpha
Theravance Inc. CEO Discusses Q3 2010 Results - Earnings Call Transcript
Oct. 21, 2010 | Source: Seeking Alpha
Theravance Inc Q2 2010 Earnings Call Transcript
July 22, 2010 | Source: Seeking Alpha
Theravance Inc. Q1 2010 Earnings Call Transcript
April 21, 2010 | Source: Seeking Alpha
Theravance, Inc. Q3 2009 Earnings Call Transcript
Oct. 27, 2009 | Source: Seeking Alpha
Theravance, Inc. Q4 2008 Earnings Call Transcript
Feb. 12, 2009 | Source: Seeking Alpha
Theravance, Inc. Q3 2008 Earnings Call Transcript
Oct. 29, 2008 | Source: Seeking Alpha
Theravance, Inc. Q2 2008 Earnings Call Transcript
Aug. 11, 2008 | Source: Seeking Alpha
Theravance Just Filed Its Quarterly Report: Net Loss Per ShareBa... - Aug. 10, 2023
Theravance: Theseus Pharmaceuticals Announces Business Highlights And Reports Second Quarter 2023 Financial Results - Aug. 10, 2023
Statement of acquisition of beneficial ownership by individuals - Aug. 10, 2023
OrbiMed Genesis GP LLC just provided an update on activist position in Theravance - July 19, 2023
James B. Tananbaum just provided an update on activist position in Theravance - July 19, 2023
Major owner of Theravance just picked up 700,000 shares - July 19, 2023
Major owner of Theravance just picked up 479,932 shares - July 19, 2023
Major owner of Theravance just picked up 479,932 shares - July 19, 2023
Theravance: Theseus Pharmaceuticals To Discontinue Enrollment In Phase 1/2 Study And Terminate Development Of The-630 In Patients With Gist - July 13, 2023
Major owner of Theravance was just granted 22,750 options and restricted shares - June 13, 2023
Theravance director was just granted 22,750 options and restricted shares - June 13, 2023
Theravance director was just granted 22,750 options and restricted shares - June 13, 2023
Theravance director was just granted 22,750 options and restricted shares - June 13, 2023
Theravance director was just granted 22,750 options and restricted shares - June 13, 2023
Submission of Matters to a Vote of Security - June 9, 2023
Annual Report to Security Holders - April 26, 2023
Theravance releases salary data. CEO sees compensation fall -37% - April 26, 2023
Theravance: Soliciting Material Under §240.14A-12 THESEUS PHARMACEUTICALS, INC. - April 26, 2023
Other preliminary proxy statements - April 14, 2023
Securities to be offered to employees in employee benefit plans - March 9, 2023
Theravance Just Filed Its Annual Report: Net Loss Per ShareTh... - March 9, 2023
Theravance: Theseus Pharmaceuticals Announces Business Highlights And Reports Fourth - March 9, 2023
Theravance's President and CEO was just granted 45,625 restricted shares - March 2, 2023
Theravance's Chief Scientific Officer was just granted 16,250 restricted shares - March 2, 2023
Theravance's See Remarks was just granted 21,250 restricted shares - March 2, 2023
Theravance's Chief Medical Officer was just granted 17,500 restricted shares - March 2, 2023
Theravance's Chief Financial Officer was just granted 17,500 restricted shares - March 2, 2023
Theravance's President and CEO was just granted 273,750 options - Feb. 21, 2023
Theravance's See Remarks was just granted 127,500 options - Feb. 21, 2023
Theravance's Chief Scientific Officer was just granted 97,500 options - Feb. 21, 2023
Theravance's Chief Medical Officer was just granted 105,000 options - Feb. 21, 2023
Theravance's Chief Financial Officer was just granted 105,000 options - Feb. 21, 2023
Statement of acquisition of beneficial ownership by individuals - Feb. 9, 2023
Daniel Estes just provided an update on share ownership of Theravance - Jan. 23, 2023
Theravance: Pan - Variant Kit Inhibitor Candidate - Jan. 5, 2023
James B. Tananbaum just provided an update on activist position in Theravance - Jan. 3, 2023
Major owner of Theravance just picked up 500,000 shares - Jan. 3, 2023
Theravance director just picked up 10,000 shares - Jan. 3, 2023
Statement of acquisition of beneficial ownership by individuals - Dec. 12, 2022
Theravance's Chief Financial Officer just picked up 1,503 shares - Dec. 1, 2022
Theravance's President and CEO just picked up 2,500 shares - Nov. 14, 2022
Notice of Effectiveness - Nov. 10, 2022
Major owner of Theravance just picked up 192,000 shares - Nov. 9, 2022
Major owner of Theravance just picked up 192,000 shares - Nov. 9, 2022
Theravance: Theseus Pharmaceuticals Announces Business And Pipeline Highlights And Reports Third - Nov. 3, 2022
Registration statement under Securities Act of 1933 - Nov. 3, 2022
Theravance Just Filed Its Quarterly Report: 12. Net Loss Per Sha... - Nov. 3, 2022
Theravance director was just granted 60,000 options - Oct. 19, 2022
Theravance director just declared ownership of no shares of Theravance - Oct. 19, 2022
Theravance: Theseus Pharmaceuticals Appoints Steven Stein, M.D. To Board Of Directors - Oct. 19, 2022
Major owner of Theravance just declared owning 4,294,621 shares of Theravance - June 13, 2022
Theravance's Chairman was just granted 45,000 options - June 13, 2022
Major owner of Theravance was just granted 30,000 options - June 13, 2022
Theravance director was just granted 30,000 options - June 13, 2022
Submission of Matters to a Vote of Security - June 13, 2022
James B. Tananbaum just provided an update on activist position in Theravance - June 13, 2022
Theravance director was just granted 60,000 options - May 18, 2022
Theravance director just declared ownership of no shares of Theravance - May 18, 2022
Theravance: Theseus Pharmaceuticals Appoints Donald Hayden To Board Of Directors - May 18, 2022
Theravance Just Filed Its Quarterly Report: 12. Net Loss Per Sha... - May 12, 2022
Theravance: Theseus Pharmaceuticals Announces Business Highlights And Reports First Quarter 2022 Financial Results - May 12, 2022
Additional definitive proxy soliciting materials and Rule 14(a)(12) material - April 25, 2022
Other definitive proxy statements - April 25, 2022
Theravance Just Filed Its Annual Report: Net Loss Per ShareTh... - March 10, 2022
Theravance: Theseus Pharmaceuticals Announces Business Highlights And Reports Fourth Quarter And Full Year 2021 Financial Results - March 10, 2022
Theravance's Chief Financial Officer was just granted 150,000 options - Feb. 23, 2022
Theravance's Chief Medical Officer was just granted 150,000 options - Feb. 23, 2022
Theravance's President and CEO was just granted 450,000 options - Feb. 23, 2022
Theravance's Chief Technical Officer was just granted 130,000 options - Feb. 23, 2022
Theravance's See Remarks was just granted 180,000 options - Feb. 23, 2022
Theravance's Chief Scientific Officer was just granted 130,000 options - Feb. 23, 2022
Statement of acquisition of beneficial ownership by individuals - Feb. 9, 2022
Major owner of Theravance just picked up 158,417 shares - Jan. 21, 2022
Major owner of Theravance just picked up 158,417 shares - Jan. 21, 2022
Major owner of Theravance just picked up 44,717 shares - Jan. 13, 2022
Major owner of Theravance just picked up 44,717 shares - Jan. 13, 2022
Theravance: Theseus Pharmaceuticals Announces First Patient Treated With The-630 In Phase 1/2 Study In Patients - Jan. 10, 2022
Theravance's Chief Financial Officer just picked up 1,971 shares - Dec. 22, 2021
Theravance's President and CEO just picked up 2,600 shares - Dec. 22, 2021
OrbiMed Genesis GP LLC just provided an update on activist position in Theravance - Nov. 18, 2021
Theravance Just Filed Its Quarterly Report: 13. Net Loss Per Sha... - Nov. 15, 2021
Theravance: Theseus Pharmaceuticals Announces Business And Program Highlights And Reports Third Quarter 2021 Financial Results - Nov. 15, 2021
Statement of acquisition of beneficial ownership by individuals - Nov. 10, 2021
On October - Oct. 27, 2021
OrbiMed Genesis GP LLC just provided an update on activist position in Theravance - Oct. 19, 2021
James just provided an update on activist position in Theravance - Oct. 18, 2021
Major owner of Theravance just picked up 1,615,427 shares - Oct. 15, 2021
Major owner of Theravance just declared 0 ownership of the company. - Oct. 15, 2021
Theravance's See Remarks just picked up 625 shares - Oct. 14, 2021
Major owner of Theravance just picked up 16,838,668 shares - Oct. 14, 2021
Theravance insider just picked up 711,479 shares - Oct. 14, 2021
Major owner of Theravance just picked up 686,649 shares - Oct. 14, 2021
Major owner of Theravance just picked up 16,838,668 shares - Oct. 14, 2021
Securities to be offered to employees in employee benefit plans - Oct. 8, 2021
Theravance's Chief Accounting Officer just disposed of 1,129 shares - Aug. 24, 2021
Theravance's Chief Accounting Officer just disposed of 2,433 shares - Aug. 23, 2021
Theravance Just Filed Its Quarterly Report: 2. Net Income Per Sh... - July 29, 2021
Theravance: Innoviva Reports Second Quarter 2021 Financial Results - July 28, 2021
Major owner of Theravance just picked up 6,268,975 shares - June 11, 2021
